Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janos Groh

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Neuron|November 14, 2024
White matter aging and its impact on brain functionJanos Groh, Mikael Simons
Glia|June 2, 2017
Neuroinflammation as modifier of genetically caused neurological disorders of the central nervous system: Understanding pathogenesis and chances for treatmentJanos Groh, Rudolf Martini
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 17, 2017
Fingolimod and Teriflunomide Attenuate Neurodegeneration in Mouse Models of Neuronal Ceroid LipofuscinosisJanos Groh, Kristina Berve, Rudolf Martini
Journal of Neuroinflammation|July 5, 2018
Teriflunomide attenuates neuroinflammation-related neural damage in mice carrying human PLP1 mutationsJanos Groh, Michaela Hörner, Rudolf Martini
The American Journal of Pathology|July 9, 2013
Similarities between inherited demyelinating neuropathies and Wallerian degeneration: an old repair program may cause myelin and axon perturbation under nonlesion conditionsRudolf Martini, Dennis Klein, Janos Groh
Brain Communications|May 12, 2021
Immune modulation attenuates infantile neuronal ceroid lipofuscinosis in mice before and after disease onsetJanos Groh, Kristina Berve, Rudolf Martini
Journal of Neuroinflammation|April 17, 2015
Endogenous antibodies contribute to macrophage-mediated demyelination in a mouse model for CMT1BDennis Klein, Janos Groh, Andreas Weishaupt, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|June 2, 2021
[Therapeutic accessibility of the retina in systemic immunomodulatory approaches in mouse models for neuronal ceroid lipofuscinosis : Comments on Bartsch et al., Der Ophthalmologe 02/2021]Rudolf Martini, Thomas Ach, Kevin Rostasy, et al.
Glia|February 15, 2014
Nonuniform molecular features of myelinating Schwann cells in models for CMT1: distinct disease patterns are associated with NCAM and c-Jun upregulationDennis Klein, Janos Groh, Jennifer Wettmarshausen, et al.
Acta Neuropathologica Communications|June 3, 2014
Non-invasive assessment of retinal alterations in mouse models of infantile and juvenile neuronal ceroid lipofuscinosis by spectral domain optical coherence tomographyJanos Groh, David Stadler, Mathias Buttmann, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Neuron|November 14, 2024
White matter aging and its impact on brain functionJanos Groh, Mikael Simons
Glia|June 2, 2017
Neuroinflammation as modifier of genetically caused neurological disorders of the central nervous system: Understanding pathogenesis and chances for treatmentJanos Groh, Rudolf Martini
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 17, 2017
Fingolimod and Teriflunomide Attenuate Neurodegeneration in Mouse Models of Neuronal Ceroid LipofuscinosisJanos Groh, Kristina Berve, Rudolf Martini
Journal of Neuroinflammation|July 5, 2018
Teriflunomide attenuates neuroinflammation-related neural damage in mice carrying human PLP1 mutationsJanos Groh, Michaela Hörner, Rudolf Martini
The American Journal of Pathology|July 9, 2013
Similarities between inherited demyelinating neuropathies and Wallerian degeneration: an old repair program may cause myelin and axon perturbation under nonlesion conditionsRudolf Martini, Dennis Klein, Janos Groh
Brain Communications|May 12, 2021
Immune modulation attenuates infantile neuronal ceroid lipofuscinosis in mice before and after disease onsetJanos Groh, Kristina Berve, Rudolf Martini
Journal of Neuroinflammation|April 17, 2015
Endogenous antibodies contribute to macrophage-mediated demyelination in a mouse model for CMT1BDennis Klein, Janos Groh, Andreas Weishaupt, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|June 2, 2021
[Therapeutic accessibility of the retina in systemic immunomodulatory approaches in mouse models for neuronal ceroid lipofuscinosis : Comments on Bartsch et al., Der Ophthalmologe 02/2021]Rudolf Martini, Thomas Ach, Kevin Rostasy, et al.
Glia|February 15, 2014
Nonuniform molecular features of myelinating Schwann cells in models for CMT1: distinct disease patterns are associated with NCAM and c-Jun upregulationDennis Klein, Janos Groh, Jennifer Wettmarshausen, et al.
Acta Neuropathologica Communications|June 3, 2014
Non-invasive assessment of retinal alterations in mouse models of infantile and juvenile neuronal ceroid lipofuscinosis by spectral domain optical coherence tomographyJanos Groh, David Stadler, Mathias Buttmann, et al.
Pageof 5